BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coccaro N, Tota G, Zagaria A, Anelli L, Specchia G, Albano F. SETBP1 dysregulation in congenital disorders and myeloid neoplasms. Oncotarget 2017;8:51920-35. [PMID: 28881700 DOI: 10.18632/oncotarget.17231] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Wong JC, Bryant V, Lamprecht T, Ma J, Walsh M, Schwartz J, Del Pilar Alzamora M, Mullighan CG, Loh ML, Ribeiro R, Downing JR, Carroll WL, Davis J, Gold S, Rogers PC, Israels S, Yanofsky R, Shannon K, Klco JM. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight 2018;3:121086. [PMID: 30046003 DOI: 10.1172/jci.insight.121086] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
2 Castellino A, Santambrogio E, Rapezzi D, Massaia M. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment. Medicina (Kaunas) 2021;57:1104. [PMID: 34684141 DOI: 10.3390/medicina57101104] [Reference Citation Analysis]
3 Pacharne S, Dovey OM, Cooper JL, Gu M, Friedrich MJ, Rajan SS, Barenboim M, Collord G, Vijayabaskar MS, Ponstingl H, De Braekeleer E, Bautista R, Mazan M, Rad R, Tzelepis K, Wright P, Gozdecka M, Vassiliou GS. SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML. Blood Adv 2021;5:2412-25. [PMID: 33956058 DOI: 10.1182/bloodadvances.2020003443] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Huang H, Deng T, Guo Y, Chen H, Cui X, Duan J, Yang Y, Guo Z, Ba Y. Gene Mutational Clusters in the Tumors of Colorectal Cancer Patients With a Family History of Cancer. Front Oncol 2022;12:814397. [DOI: 10.3389/fonc.2022.814397] [Reference Citation Analysis]
5 Chen L, Miao Y, Liu M, Zeng Y, Gao Z, Peng D, Hu B, Li X, Zheng Y, Xue Y, Zuo Z, Xie Y, Ren J. Pan-Cancer Analysis Reveals the Functional Importance of Protein Lysine Modification in Cancer Development. Front Genet 2018;9:254. [PMID: 30065750 DOI: 10.3389/fgene.2018.00254] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
6 Perdue MV, Mascheretti S, Kornilov SA, Jasińska KK, Ryherd K, Einar Mencl W, Frost SJ, Grigorenko EL, Pugh KR, Landi N. Common variation within the SETBP1 gene is associated with reading-related skills and patterns of functional neural activation. Neuropsychologia 2019;130:44-51. [PMID: 30009840 DOI: 10.1016/j.neuropsychologia.2018.07.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
7 Yu J, Sun J, Du Y, Patel R, Varela JC, Mori S, Chang CC. Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by NPM1 Mutation. Diagnostics (Basel) 2021;11:986. [PMID: 34072516 DOI: 10.3390/diagnostics11060986] [Reference Citation Analysis]
8 Crisà E, Nicolosi M, Ferri V, Favini C, Gaidano G, Patriarca A. Atypical Chronic Myeloid Leukemia: Where Are We Now? Int J Mol Sci 2020;21:E6862. [PMID: 32962122 DOI: 10.3390/ijms21186862] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
9 Antonyan L, Ernst C. Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development. Front Neurosci 2022;16:813430. [DOI: 10.3389/fnins.2022.813430] [Reference Citation Analysis]
10 Lee P, Yim R, Yung Y, Chu HT, Yip PK, Gill H. Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome. Int J Mol Sci 2021;22:10232. [PMID: 34638574 DOI: 10.3390/ijms221910232] [Reference Citation Analysis]